HAROON SAEED: Open Payments
NPI 1750597696 · DURHAM, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,834 in 108 payments from 8 companies in 2025. Trend: 2023 $1,724 · 2024 $1,392 · 2025 $2,834
Food & beverage: $2,834
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 15 | $639 |
| Alkermes, Inc. | 21 | $621 |
| Lundbeck LLC | 16 | $429 |
| Otsuka America Pharmaceutical, Inc. | 20 | $403 |
| Janssen Pharmaceuticals, Inc | 9 | $272 |
| Neurocrine BioSciences, Inc. | 9 | $241 |
| Teva Pharmaceuticals USA, Inc. | 16 | $184 |
| Luye Pharma (USA) Ltd. | 2 | $45 |
Products named: ABILIFY ASIMTUFII, COBENFY, ARISTADA, INVEGA SUSTENNA, INGREZZA, VIVITROL, LYBALVI, UZEDY.
Industry payments across NC — which companies pay providers there.
